Matthew R. Patterson - Insider Trading & Ownership

Entity
Individual
Location
C/O Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury, NJ
Summary
The estimated net worth of Matthew R. Patterson is at least $309K dollars as of May 28, 2024. Matthew R. Patterson is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $309K.
All Insider Reports
All Insider Reports

Ownership of Matthew R. Patterson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QTTB Q32 Bio Inc. Director $309K Jun 14, 2023
VOR Vor Biopharma Inc. Director May 23, 2024

Insider Transactions Reported by Matthew R. Patterson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.